Solid biosciences announces fda lifts clinical hold on ignite dmd clinical trial

Solid biosciences announces fda lifts clinical hold on ignite dmd clinical trial.solid biosciences inc - fda acknowledged that company satisfactorily addressed all clinical hold questions..solid biosciences inc - working diligently to complete all activities necessary to resume dosing, which co expects to occur in q1 of 2021.solid biosciences inc - implemented and shared with fda manufacturing process changes that remove majority of empty viral capsids.solid biosciences inc - reducing maximum weight of next two patients dosed to 18 kg per patient.
SLDB Ratings Summary
SLDB Quant Ranking